Longitudinal multiomics profiling indicates that aging does not progress uniformly across individuals, but follows distinct molecular trajectories that can be tracked over time within a single person. Repeated sampling across molecular layers — genomic, proteomic, metabolomic and microbial — identifies which systems in a given individual are deteriorating fastest, rather than assigning a single composite age score. The implication is that interventions may be most effective when matched to a person's dominant pattern of decline.
Key Points
- Aging follows individual molecular trajectories, not one uniform pathway
- Repeated sampling identifies which systems decline fastest per person
- Multiomic tracking supports intervention matched to dominant decline pattern
Longevity Analysis
Population averages have long obscured the fact that two people of the same chronological age may be aging through entirely different mechanisms — one through metabolic and energy-generating pathways, another through immune dysregulation or impaired tissue repair. Serial molecular measurement converts aging from an abstraction into a readable signal, allowing the specific system under strain to be identified before clinical disease appears. The practical value depends on repetition: a single panel describes a moment, while sustained tracking over years exposes the slope, and the slope is what intervention is meant to change.
Original published by Nature Aging, by Hannah Walters.